EOFlow logo

EOFlow

Asia, Kyonggi-do, South Korea, Seongnam

Description

EOFlow provides user friendly, smart wearable drug delivery solutions.

Investor Profile

EOFlow has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
  • Wearables
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does EOFlow frequently co-invest with?

Ascensia Diabetes Care
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Global Health Funds
North America, New York, United States, New York
Co-Investments: 1
AXA Investment Managers
Europe, Ile-de-France, France, Puteaux
Co-Investments: 1
Cirrus Logic
North America, Texas, United States, Austin
Co-Investments: 1
Features Capital
North America, Vermont, United States, Norwich
Co-Investments: 1
Hikma Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
JDRF T1D Fund
North America, Massachusetts, United States, Boston
Co-Investments: 1
Aphelion Capital
North America, Colorado, United States, Littleton
Co-Investments: 1
Able Partners
North America, New York, United States, New York
Co-Investments: 1
Alpha Wave Global
North America, Florida, United States, Miami
Co-Investments: 1

What are some of recent deals done by EOFlow?

Biolinq

San Diego, California, United States

Biolinq develops a wearable biosensor platform that is capable of measuring blood level information.

BiotechnologyHealth CareMedical DeviceWearables
Series BNov 2, 2021
Amount Raised: $100,000,000